Improving cancer immunotherapy development through advanced engineering tools
Administrative Core
This study is working on improving cancer treatments by combining new engineering methods with immunotherapy, so that patients can eventually receive better and more effective therapies.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10896033 on NIH RePORTER |
What this research studies
This research focuses on enhancing the development of immunotherapy for cancer by integrating advanced engineering techniques. The project aims to create a robust Immuno-engineering Translation Accelerator (ITA) that streamlines the pre-clinical therapy development process. The Administrative Core will support this initiative by facilitating collaboration among researchers, organizing workshops, and ensuring effective management of the project. Patients may benefit from improved therapies that emerge from this innovative approach to cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals diagnosed with various types of cancer who may be eligible for immunotherapy.
Not a fit: Patients with non-cancerous conditions or those not eligible for immunotherapy may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy options for cancer patients.
How similar studies have performed: Other research has shown promise in using engineering approaches to enhance immunotherapy, indicating a potential for success in this area.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Odde, David J. — University of Minnesota
- Study coordinator: Odde, David J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.